Silmitasertib Uses, Dosage, Side Effects and more
Silmitasertib is under investigation in clinical trial NCT03904862 (Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery).
| Trade Name | Silmitasertib |
| Generic | Silmitasertib |
| Silmitasertib Other Names | Silmitasertib |
| Type | |
| Formula | C19H12ClN3O2 |
| Weight | Average: 349.77 Monoisotopic: 349.06180435 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
